日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comprehensive Analysis of Metabolic Isozyme Targets in Cancer

癌症代谢同工酶靶点的综合分析

Marczyk, Michal; Gunasekharan, Vignesh; Casadevall, David; Qing, Tao; Foldi, Julia; Sehgal, Raghav; Shan, Naing Lin; Blenman, Kim R M; O'Meara, Tess A; Umlauf, Sheila; Surovtseva, Yulia V; Muthusamy, Viswanathan; Rinehart, Jesse; Perry, Rachel J; Kibbey, Richard; Hatzis, Christos; Pusztai, Lajos

Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer

预测基底样三阴性乳腺癌新辅助化疗方案(Durvalumab联合白蛋白紫杉醇和高剂量多柔比星/环磷酰胺)疗效的标志物

Blenman, Kim R M; Marczyk, Michal; Karn, Thomas; Qing, Tao; Li, Xiaotong; Gunasekharan, Vignesh; Yaghoobi, Vesal; Bai, Yalai; Ibrahim, Eiman Y; Park, Tristen; Silber, Andrea; Wolf, Denise M; Reisenbichler, Emily; Denkert, Carsten; Sinn, Bruno V; Rozenblit, Mariya; Foldi, Julia; Rimm, David L; Loibl, Sibylle; Pusztai, Lajos

Network propagation-based prioritization of long tail genes in 17 cancer types

基于网络传播的17种癌症类型中长尾基因的优先级排序

Mohsen, Hussein; Gunasekharan, Vignesh; Qing, Tao; Seay, Montrell; Surovtseva, Yulia; Negahban, Sahand; Szallasi, Zoltan; Pusztai, Lajos; Gerstein, Mark B

Multi-Omics Investigation of Innate Navitoclax Resistance in Triple-Negative Breast Cancer Cells.

利用多组学方法研究三阴性乳腺癌细胞中固有的Navitoclax耐药性

Marczyk Michal, Patwardhan Gauri A, Zhao Jun, Qu Rihao, Li Xiaotong, Wali Vikram B, Gupta Abhishek K, Pillai Manoj M, Kluger Yuval, Yan Qin, Hatzis Christos, Pusztai Lajos, Gunasekharan Vignesh

A prokaryotic viral sequence is expressed and conserved in mammalian brain.

一种原核病毒序列在哺乳动物大脑中表达并保守

Yeh Yang-Hui, Gunasekharan Vignesh, Manuelidis Laura

Differentiation-dependent changes in levels of C/EBPβ repressors and activators regulate human papillomavirus type 31 late gene expression

分化过程中C/EBPβ抑制因子和激活因子水平的变化调控人乳头瘤病毒31型晚期基因的表达。

Gunasekharan, Vignesh; Haché, Guylaine; Laimins, Laimonis